Skip to main content

Table 3 Postoperative complications

From: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study

Variables

Total (n = 201)

TP(n = 50)

TC (n = 151)

p

n (%)

n (%)

n (%)

Postoperative complications

53 (26.4)

10 (20)

43 (28.5)

0.32

Pneumonia

11 (5.5)

1 (2)

10 (6.6)

0.298

Atelectasis

7 (3.5)

0 (0)

7 (4.6)

0.249

Pleural effusion

25 (12.4)

8 (16)

17 (11.3)

0.526

Chylothorax

2 (1.0)

0 (0)

2 (1.3)

1

Empyema

2 (1.0)

0 (0)

2 (1.3)

1

Respiratory failure

7 (3.5)

0 (0)

7 (4.6)

0.196

Heart failure

7 (3.5)

0 (0)

7 (4.6)

0.196

Anastomotic fistula

15 (7.5)

1 (2)

14 (9.3)

0.122